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Abstract 10 
Sub-Saharan Africa has the highest proportion of undernourished people in the world, along 11 
with the highest number of people living with HIV and AIDS. Thus, as a result of high levels 12 
of food insecurity many HIV patients are also undernourished. The synergism between HIV 13 
and undernutrition leads to poor treatment adherence and high mortality rates. Undernutrition 14 
has a debilitating effect on the immune system due to key nutrient deficiencies and the 15 
overproduction of reactive species (oxidative stress), which causes rapid HIV progression and 16 
the onset of AIDS. Therapeutic food supplementation used in the treatment of severe acute 17 
malnutrition is being applied to HIV palliative care; however little biochemical data exists to 18 
highlight its impact on oxidative stress and immune recovery. In addition, as most food 19 
supplements are imported by donor agencies, efforts are being put into local therapeutic food 20 
production such as the Food Multi Mix (FMM) concept to ensure sustainability.  The purpose 21 
of this review is to highlight studies that examine the effectiveness of food supplementation in 22 
undernourished HIV patients in Sub-Saharan Africa; noting the parameters used to measure 23 
efficacy, as well as the long-term feasibility of supplementation.       24 
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 29 
Introduction  30 
According to the Food and Agriculture Organisation (FAO), the number of chronically 31 
undernourished people in the world stood at 805 million between 2012 and 2014 (1). 32 
Undernourishment occurs as a result of an energy intake less than the amount needed for light 33 
activity and to maintain an appropriate weight in proportion to height (2). Due to significant 34 
nutrient deficiencies, undernourished individuals, particularly children, are considerably more 35 
susceptible to acquiring infectious diseases, including HIV. Sub-Saharan Africa has the highest 36 
proportion of undernourished people in the world, with close to one in four of its population 37 
considered chronically undernourished (1). The region was also home to approximately 24.7 38 
million people living with HIV in 2013; accounting for nearly 70% of the global total of new 39 
HIV infections (3). Given the increased availability of antiretroviral treatment (ART) in low-to-40 
middle-income countries, the high prevalence of undernutrition can pose a significant hurdle 41 
to AIDS recovery; as food insecurity has been identified as a primary obstacle to ART 42 
adherence (4). To date, ART coverage in Sub-Saharan Africa is estimated at 37%, and roughly 43 
three out of every four people currently on ART live in Sub-Saharan Africa (3).  44 
According to WHO guidelines, nutritional support should be incorporated into HIV care 45 
alongside ART.  Recommendations include an increase in energy intake of up to 50% 46 
compared to an HIV negative individual, but a normal intake of micronutrients and protein (5). 47 
Micronutrients play important functional roles in the human immune response, however, a 48 
number of micronutrient deficiencies have been reported in HIV positive individuals. This has 49 
been linked to poor nutrient absorption due to intestinal cellular damage caused by oxidative 50 
stress.  51 
 52 
Nutrients, Immunity and HIV infection 53 
Micronutrients in particular antioxidant minerals such as selenium, zinc, and vitamins A, C and 54 
E play a key functional role in an active immune response (6). For example, the antioxidant role 55 
of vitamin A and in particular its role in maintaining mucosal immunity makes it an important 56 
dietary component (7).  A function for vitamin A in enhancing T Helper Type 2 cytokine 57 
production and secretory IgA response to viral infections especially at high doses has also been 58 
reported (8). In addition, carotenoids and other vitamin A compounds have been shown to 59 
inhibit reverse transcriptase in HIV-1 and HIV-2 (9). Similarly, vitamin C has been shown to 60 
inhibit the HIV virus in vitro (10).  61 
3 
 
The combination of vitamin A deficiency and wasting have been identified as predictors of 62 
mortality in HIV disease (11).  Low zinc and iron levels have also been associated with immune 63 
abnormalities, increased susceptibility to infections and gastrointestinal malfunction with 64 
diarrhoea (12). Such data supports the argument for micronutrient supplementation in HIV 65 
patients, however consideration must be taken as high doses of iron can induce oxidative stress, 66 
stimulate microbial growth; while excess zinc can cause HIV gene expression, multi-67 
mineralization and integration (13, 14). 68 
 69 
Antioxidant defence systems (ADS) are essential in limiting various reactive species (RS) from 70 
causing intestinal cellular damage (15, 16). Immune activation can contribute considerably to the 71 
overproduction of RS at the site of infection such as the intestinal area. In HIV infected 72 
individuals who also face the double-burden of also being undernourished, the level of 73 
antioxidant protection may not be present to thwart this overproduction; which inevitably leads 74 
to oxidative stress (17) . With the onset of oxidative stress, intestinal cells can become further 75 
degraded as RS oxidize the polyunsaturated fatty acid component of membranes, disrupting 76 
cellular structure and function in the process (15). This causes nutrient malabsorption, which is 77 
linked to wasting in HIV patients (16).  In addition, oxidative stress-related tissue damage caused 78 
during HIV infection triggers the activation of nuclear factor kappa B (NF-κB), which in turn 79 
can further enhance HIV replication (18).  80 
The extent of oxidative damage can be determined by measuring biochemical parameters such 81 
as glutathione (GSH), glutathione peroxidase (GPx); malondialdehyde (MDA), or total 82 
antioxidant status (19, 20, 21) Glutathione has been shown to be of importance in immune function 83 
and restoration of CD4 T lymphocyte levels in HIV infection (22, 23, 24). During an HIV infection, 84 
not only does GSH decrease but there is also an increase in oxidised glutathione (GSSG) and 85 
protein-bound glutathione (GSSP) (25).  The accompanying change in GSH:GSSG ratio 86 
indicates a change in redox status and increased oxidative stress (25). Such oxidative stress can 87 
be exacerbated by folate deficiency, which is associated with increased production of 88 
homocysteine, a potential RS (25).   89 
Sulphur-containing amino acids are important in metabolism and immune function, which can 90 
become depleted in the onset of protein deficiency (25). Furthermore, should protein also be 91 
deficient there would be insufficient building blocks for glutathione synthesis (cysteine) and 92 
the methylation cycle (methionine) (25). Cysteine and methionine are both important in the 93 
methylation cycle (crucial to folate, B12 and homocysteine metabolism) and the glutathione 94 
pathway (25). Protein deficiency would also lead to biochemical (metabolic) adaptations, which 95 
4 
 
would mean various critical enzyme systems and immune globulin synthesis may become 96 
compromised (25). The loss of lean tissue, which is a characteristic of HIV wasting, would 97 
ultimately lead to patient death.  98 
 99 
Figure 1: the Infection – Malnutrition Cycle 100 
 101 
HIV, Food Insecurity and Undernutrition 102 
The synergism of HIV and undernutrition is unfortunate as one has a debilitating effect on the 103 
other, often in spite of access to ART. An HIV positive person in a food insecure household 104 
would not consume an adequate diet consisting of nutrients required for maintaining a 105 
functional immune system to prevent opportunistic infections (26).This situation usually leads 106 
to a rapid onset of AIDS, which causes a decrease in productivity due to illness and death.  HIV 107 
affected households are thus more likely to experience income losses, which in turn  108 
exacerbates  food insecurity and low ART adherence, as difficult situations may arise such as 109 
choices  between  purchasing either food or treatment (27).    110 
As a general rule, drug adherence is difficult to achieve in an undernourished patient. 111 
Antiretroviral treatment has been shown to stimulate appetite in HIV patients, which helps 112 
with body mass recovery and improves immune function (28, 29). Yet in a food-insecure 113 
household this may not be desirable as there would be insufficient food to satisfy a stimulated 114 
appetite. Current evidence suggests that food insecurity is a significant contributor to non-115 
compliance with ART, and may offset the benefits of treatment. For example, HIV patients in 116 
Kenya who were offered free ART from the Medecins Sans Frontiers, cited fears of the 117 
potential side effects of taking ART on an empty stomach as a key reason for declining 118 
treatment (30). Similarly, in Rwanda, patients interviewed listed the concern of having too 119 
much appetite without the food to fulfil it as an obstacle to maintaining adherence (4). 120 
Considerable adverse effects have been observed in food insecure patients on ART such as 121 
hepatic toxicity (31). In a Ugandan study, it was observed that food insecurity was heavily 122 
associated with non-adherence to ART, incomplete viral suppression and having a CD4 count 123 
less than 350 cell mm3 (32). This phenomenon has presented the argument for nutrition 124 
intervention to be formally introduced into HIV palliative care. Given that many HIV 125 
infected persons in low-income countries also suffer from the complications of acute to 126 
severe malnutrition, the benefits of using ready-to-use-therapeutic foods (RUTF) is being 127 
investigated among this population. Research has indicated that RUTF use is generally 128 
accepted by HIV infected persons as a means to counteract the adverse effects of ART; and 129 
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has been described as “food with medicinal qualities", making it less likely to face any 130 
cultural perceptions and practices associated with food including sharing and fasting (33). 131 
 132 
Food Supplementation 133 
Food intervention strategies in food-insecure countries have traditionally involved imported 134 
food rations, which are not the most financially sustainable. In Mozambique, it was estimated 135 
the cost of providing food assistance to HIV infected persons at $288 over a 3 month period, 136 
and highlighted a significant portion of costs was related to overheads such as transport (21). 137 
Thus the local production of RUTF in food-insecure regions is being investigated, albeit on a 138 
low level. Preliminary technical guidelines are available for small and medium-scale 139 
therapeutic food production in resource-limited settings (34). Local therapeutic food production 140 
programmes have been successfully implemented in a number of countries such as Niger, the 141 
Congo and Malawi. The majority of therapeutic foods have been designed as treatment for 142 
acute to severe malnutrition however research into how therapeutic foods can complement 143 
ART as part of HIV care is also ongoing (35). Despite some being locally sourced, most 144 
ingredients of RUTF are either imported or donated by the World Food Programme (WFP) (36). 145 
Thus operations remain largely unsustainable despite local production. In Malawi, the cost of 146 
local therapeutic food production was estimated at $2.60/kg, with approximately 54% of this 147 
price covering the cost of imported ingredients (35).In Kenya, a nutrient-dense therapeutic food 148 
formula using all locally-sourced ingredients was developed, piloted for taste testing and found 149 
to be well adhered to by participants (37).   150 
 151 
Aim of Review 152 
To date the biochemical aspect of HIV infection and its relationship with antioxidant nutrients 153 
has not often featured in nutritional intervention studies. Nevertheless, the use of food 154 
supplementation, in particular micronutrient-fortified, ready-to-use therapeutic foods (RUTF) 155 
as part of nutrition intervention strategies has gained momentum. The aim of this review is to 156 
highlight the most recent studies related to food supplementation in HIV infected adults in Sub-157 
Saharan Africa; analysing where available, measurable outcomes such as weight gain and ART 158 
adherence with a view to providing evidence for debate on this important topic in Africa.  159 
 160 
 161 
Selected Studies 162 
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Relevant studies were identified by a search conducted in the PUBMED database.  Keywords 163 
used were “food” “HIV” “supplementation” and “intervention”. The search was confined to a 164 
ten year period (2004-2014) and studies were chosen based on pre-defined inclusion/exclusion 165 
criteria.  Studies were considered relevant if they measured at least two of the following 166 
outcomes including Weight/BMI, ART adherence and CD4 count. Studies were excluded if 167 
they were conducted outside of Sub-Saharan Africa, involved a non-food intervention and/or 168 
if there was either no article full-text available or the full text was not accessible free of charge.  169 
A total of ten primary studies were identified and seven met the criteria to be included in this 170 
review. Two studies were conducted outside of Sub-Saharan Africa (Haiti and India) and one 171 
study involved a non-food intervention. All seven studies  (one in Zambia, two in Uganda and 172 
four in Malawi)  were conducted among adults aged 18 and older (Table 1). Data extracted 173 
from each study included type of study, description of food intervention, location, duration, 174 
WHO clinical stage, sample size, and measurable outcomes. In three studies participants were 175 
described as food-insecure and in two studies participants were treatment naïve. In all eight 176 
studies participants were malnourished and/or wasted and presented with WHO clinical stage 177 
III or IV of HIV infection.  178 
 179 
 180 
 181 
 182 
 183 
 184 
 185 
 186 
 187 
 188 
 189 
 190 
 191 
 192 
 193 
 194 
Table 1: Data from seven primary studies included in this review 195 
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Author and 
Date 
Participant 
No. 
Duration Location Supplement Weight 
gain 
BMI 
increase 
ART 
adherence 
Cantrell et al 
(2008) 
636  11 months Zambia CSB 6.3 kg  N/A High  
Ndekha et al 
(2009) 
491  3 ½ months Malawi,  RUFS vs. 
CSB 
5.6 kg 
RUFS; 4.3 
kg CSB 
2.2 kg/m2 
RUFS; 1.7 
kg/m2 CSB 
High 
Bahwere et 
al. (2009) 
60  3 months Malawi Local RUTF  2.5 kg 0.8 kg/m2 N/A 
Ahoua et al. 
(2011) 
1106 29 months Kenya 
and 
Uganda 
RUTF 
Plumpy’Nut 
®   
4 kg  
 
1.7 kg/m2 N/A 
Oosterhout 
and Ndekha 
(2009). 
593  6 ½ months Malawi RUFS vs. 
CSB 
6.9 kg 
RUFS; 6.8 
kg CSB 
2.7 kg/m2  
RUFS; 2.6 
kg/m2 CSB    
High 
Bowie et al 
(2005) 
360  14 months Malawi WFP food 
basket 
N/A 0.46 kg/m2  N/A  
Rawat et al. 
(2014) 
904  12 months Uganda WFP food 
basket 
N/A 
MUAC 6.7 
mm 
0.6 kg/m2 N/A  
CSB: Corn-soy-blend 196 
RUFS: Ready-to-use fortified spread 197 
RUTF: Ready-to-use-therapeutic food 198 
WFP: World Food Programme  199 
MUAC: Mid-upper-arm-circumference  200 
 201 
In Zambia, approximately 54.6% of the 1.1 million people living with HIV have access to ART 202 
as of September 29th 2014 (38). In 2013, there were approximately 27,000 AIDS related deaths 203 
(38). A non-randomised study by Cantrell and colleagues investigated the effect of food 204 
supplementation on ART adherence in HIV adults in Zambia (39). Food supplementation 205 
consisted of micronutrient fortified corn-soya blend (CSB) containing 6.2kg of protein; and 206 
620ml of vegetable oil per month for each individual ration. The programme ran from May 207 
2004 to March 2005 (11 months) and involved 636 HIV positive adults with a mean CD4 cell 208 
8 
 
count of 131cell mm3. One hundred and thirty four (22%) of participants had a CD4 count of 209 
less than 50 cells mm3. Three hundred and forty seven (79%) were categorised as WHO clinical 210 
stage III or IV, while 92 (21%) were categorised in clinical stage I or II.   211 
The 411 women had a mean baseline weight of 52.9 kg, while the 218 men had a mean baseline 212 
weight of 56.1 kg. All participants were described as food-insecure. Food distribution was 213 
based on whether the patient was a primary income earner, in which case they would receive 214 
an individual ration along with additional rations sufficient for six household members. 215 
Participants classified as the “food group” began food rations in September 2004, whereas the 216 
“control group” were assigned to receive rations at a later date. ART adherence was measured 217 
within the first 12 months, according to the medication possession ratio (MPR), where the 218 
number of days late for pharmacy refills was expressed as a percentage of the total days of 219 
therapy, then subtracted from 100%. It was reported that adherence was higher in the food 220 
group compared to the control group, 70% (258/366) patients in the food group achieved an 221 
adherence of 95%, compared with 48% (79/166) in the control group. Differences in weight 222 
gain between the food and control group were 5.4kg vs. 5.1kg respectively after 6 months, and 223 
6.3kg vs. 5.4kg after 12 months, which although not significant, was described as a “trend 224 
towards modest benefit”. There was no reported increase in CD4 count in the food group 225 
compared to the control group. All food rations used in the study were donated by the WFP (39) 226 
 227 
Approximately 46% of Malawi’s HIV population of one million people were receiving ART 228 
by 2014; of which roughly 90% were adults (38).  A randomised, investigator blinded, controlled 229 
trial in Malawi  reported on the effectiveness of ready-to-use fortified spread (RUFS) versus 230 
Corn-Soya-Blend (CSB) in achieving weight gain in HIV adults  after 3 ½ months (39).  The 231 
study consisted of 491 HIV adults receiving ART. All participants had a BMI of less than 18.5 232 
kg/m2, a CD4 count of less than 250/mm3, and were categorised as WHO clinical stage III or 233 
IV. Primary outcomes included BMI and fat-free mass, while secondary outcomes included 234 
ART adherence, survival, CD4 count, HIV viral load, and quality of life. After 14 weeks, 235 
mortality rates were similar in both groups (27% in RUFS versus 26% in CSB).  236 
There was no significant difference in ART adherence, which was high in both groups; neither 237 
was there a difference in CD4 cell count, viral load or quality of life. Participants in the RUFS 238 
group reported a 13% weight increase compared to a 10% increase in the CSB group. Fat-free 239 
mass contributed to 2.9 kg (51.8%) of the 5.6 kg weight gain in the RUFS group and 2.2 kg 240 
(51.2%) of the 4.3 kg weight gain in the CSB group. BMI increased by 2.2 in the RUFS group, 241 
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compared to 1.7 in the CSB group. In this study, the CSB was priced at US$5.40 per patient 242 
per month whereas the RUFS cost US$16.00 per patient per month, which was approximately 243 
$1 more expensive than first line ART (40). 244 
 245 
A prospective descriptive study highlighted the effects of a locally produced ready-to-use 246 
therapeutic food (RUTF) in 60 HIV positive adults in Malawi (41). A total of 45/60 (75%) of 247 
participants were at WHO clinical stage IV and 15 (25%) were at WHO clinical stage III. 248 
Participant eligibility included a BMI of less than 17 kg/m2 and a middle-upper-arm 249 
circumference (MUAC) of less than 210 mm.  250 
 Participants were given 500g daily of the RUTF, which consisted of chick peas, sesame seeds, 251 
vegetable oil, sugar, maize and a micronutrient complex. This provided a daily amount of 252 
2681kcal of energy, 61.5g protein, 24mg niacin, 2.5mg vitamin B6, 8 µg vitamin B12, 241.5mg 253 
vitamin C, and 62mg of zinc, amongst other micronutrients. Only 8 participants (13.3%) were 254 
already on triple ART including stavudine, lamivudine and nevirapine.  A daily dose of 255 
cotrimoxazole (960mg) was also given to participants for the three month duration of the study. 256 
Adherence to the food supplement was measured by the number of finished pots and the 257 
measurable outcomes included MUAC, BMI, weight gain and physical activity. Out of 60 258 
participants, 44 (73.3%) reported increases in weight, MUAC and BMI (2.5kg, 15mm and 0.8 259 
kg/m2 respectively).  A lower BMI, MUAC and weight was observed in participants already 260 
on ART at the start of the study compared to ART naive participants. The amount of 261 
participants able to walk to the clinic increased from 25 to 47 (41.7% to 78.3%).  The cost of a 262 
500g/day ration of RUTF was valued at $45.90/person/month, which was more cost effective 263 
than other nutrition interventions including the standard food aid supplement (CSB and oil) 264 
valued at $53.25/month (41). 265 
 266 
According to UNAIDS, Kenya has the fourth largest ART programme among low and middle 267 
income countries, although only 41% of the estimated 1.6million HIV population currently 268 
receives treatment (38). Following close behind at fifth is neighbouring country Uganda, which 269 
had 38% of its estimated 1.6million HIV population on ART as of 2014. A retrospective cohort 270 
analysis) involved the use of RUTF originally developed for treatment of severe malnutrition 271 
such as Plumpy’Nut® and Nutriset, aimed to investigate nutritional outcome in HIV adults and 272 
to highlight the factors behind treatment failure (30). Over a two-year period (March 2006 to 273 
August 2008) a total of 1106 malnourished adults from a Kenyan and a Ugandan HIV 274 
programme participated in the study. Participants had a median CD4 count of 114 cells/mm3 275 
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and a BMI of less than 17 kg/m2. A total of 617 participants were severely malnourished 276 
(55.8%), while 489 were moderately malnourished (44.2%).  The amount of participants 277 
categorised in either WHO clinical stage III or IV was 705 (63.7%).  Out of the 790 adults 278 
eligible for ART, 133 (16.8%) were already on treatment, while 470 (59.5%) began treatment 279 
either at the start or during the programme. A total of 187 (23.7%) participants did not receive 280 
any treatment for the duration of the study. The RUTF consisted of a micronutrient fortified, 281 
energy dense spread of peanut, milk powder, oil and sugar. Participants achieving BMI ≥ 18 282 
kg/m2 with no oedema for a minimum of two weeks were defined as “cured”, based on the 283 
programme guidelines and permitted to exit the study. A total of 524 participants (47.4%) 284 
achieved this target and were discharged after a median period of 3.7 months, with a median 285 
weight gain of 8 kg (1.6g/kg/day). Forty nine participants (4.4%) were discharged as uncured 286 
after a median of 7.1 months with a median CD4 count of 292 cells/mm3 In total, 531 287 
participants (48.0%) failed to complete the programme, which included 250  (22.6%) whom 288 
defaulted and 132 (11.9%) whom died; both of which were severely malnourished, received 289 
nutritional treatment for less than three months, had low CD4 cell counts (96 cells/mm3 and 36 290 
cells/mm3 respectively) and/or received no ART despite being eligible (42). 291 
 292 
A retrospective study conducted in Malawi involving 593 HIV wasted adults investigated the 293 
effects of food supplementation versus no nutritional intervention (43).  Participants were 294 
previously ART naive, either WHO clinical stage III or IV, a BMI of less than 18.5 kg m2 and 295 
CD4 count less than 250 cells/mm3.  All initiated ART upon enrolment, and were compared to 296 
a historical control group that received no supplementation but was given a dosage of 297 
cotrimoxazole prophylaxis. Outcomes were measured at the end of supplementation at 14 298 
weeks and again at 26 weeks. Approximately half (245) of participants in the supplement group 299 
received CSB, while the remainder (244) received an RUFS; both of which were fortified with 300 
micronutrients. Higher increases of BMI were reported in the supplemented group compared 301 
to the control group. Although eight (4%) more people receiving RUFS died , it was more 302 
effective at increasing BMI and weight than the CSB, as increases of 0.5 kg m2 and 1.2 kg 303 
respectively were observed. However, only 9% of participants receiving the RUFS supplement 304 
had a BMI that was less than 18 kg m 2. In comparison to the control group, treatment adherence 305 
improved among the supplemented group with only four people stopping ART (one on RUFS 306 
vs. three on CSB). There was no significant difference in CD4 count. The CSB supplement 307 
was priced at a monthly cost of $5USD, while the RUFS was priced at $16USD/month, which 308 
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at the time of the study was one dollar more expensive than first line ARV treatment in Malawi 309 
(43). 310 
 311 
An observational study described the effect of food supplementation on food-insecure HIV 312 
adults needing home-based care in Malawi (43). Food was provided to households by the World 313 
Food Programme (WFP), and contained monthly rations of 50kg maize, 5kg beans, 7.5kg 314 
‘Likuni Phala’ (cereal-soya blend). Half of the households in the study also received a random 315 
allocation of 4 litres of oil, which was not strictly adhered to.  316 
The study consisted of 360 participants, and food distribution ran for 14 months from July 2003 317 
to September 2004. The study was divided into three periods; January 2003 to July 2003; 318 
August 2003 to November 2003, and mid-November 2003 to July 2004. Approximately 97 319 
enrolled patients were chronically ill; up to 70% presented advanced stages of HIV infection 320 
(WHO clinical stage IV). Half of the participants were malnourished upon enrolment, with a 321 
BMI of less than 18.5kg/m2. Mortality rate was high, as 112 (one-third) of participants died 322 
within the first four months. By the end of the study, 199 participants (56%) had died. Only 22 323 
participants survived through all three periods. A slight increase in BMI was observed among 324 
these participants (0.49 kg/m2 per 100 days by the second survey and 0.46 kg/m2 by the third 325 
survey), but this  was not significant. Participants assigned to receive oil supplements showed 326 
no significant change mean BMI, although survival was better in this group. At the time of this 327 
study, ART was not available for free in Malawi and all participants were treatment naïve.   328 
Changes in CD4 count were not reported in this study. Although ART adherence was not 329 
specified, it was indicated that participants with increased physical activity were now able to 330 
walk to Voluntary Counselling and Testing centres and enrol in ARV programs.  (44) 331 
      332 
 A prospective quasi-experimental study  evaluated the impact of a WFP food basket (200g 333 
maize meal, 40g pulses, 10g vitamin A–fortified vegetable oil, 5g iodized salt, 50g 334 
micronutrient fortified CSB per person per day) provided monthly over a 12 month period 335 
(August 2008 to October 2009) to HIV adults in Uganda that were both food-insecure and ART 336 
naïve (45).  337 
A total of 904 adults participated in the initial study, based on their eligibility to receive the 338 
WFP food basket and having a CD4 count between 200 and 450 cells/m3; while 604 adults 339 
were part of the follow-up study. The food basket provided approximately 1100 kcal per person 340 
per day and resulted in a BMI increase of 0.6 kg/m2 and a MUAC increase of 6.7 mm. No 341 
significant association was observed between food assistance and CD4 count, however in 342 
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participants with a CD4 count greater than 350 cells/m3, haemoglobin concentrations increased 343 
by approximately 1.0 g/dL (45). 344 
 345 
 346 
Types of Food Supplementation  347 
In the studies highlighted in this review, food supplementation predominantly consisted of 348 
RUTF and CSB, both of which had a high nutrient density and were developed to treat severe 349 
malnutrition. Notable differences existed between these two supplements, namely preparation 350 
methods and cost. As the RUTF did not require cooking, it was considered less likely to be 351 
shared with other household members, compared with the CSB, which was considered to be 352 
more culturally accepted. The CSB was also significantly less expensive than the RUTF.  353 
According to Ahoua and colleagues the currently available RUTF was designed to treat 354 
paediatric malnutrition, it may not be the most suitable formulation for treatment of 355 
malnutrition in HIV infected adults (41). In two studies the effect of WFP food rations were 356 
examined (43, 44). In these studies both study populations were ART naïve, which may account 357 
for the small-to-modest increases in BMI observed (0.6 kg/m2 and 0.49 respectively). Although 358 
the food ration studies showed little to no improvement in anthropometric gains it highlighted 359 
the impact of HIV-related complications on nutritional recovery and survival. It also 360 
highlighted the ineffectiveness and lack of sustainability of food distribution programmes.  361 
 362 
All but one study used an intervention strategy based on imported RUTF and food rations. The 363 
locally produced RUTF examined by Bahwere and colleagues performed well in improving 364 
physical activity of participants; and was more affordable than imported food supplements (41).  365 
Studies were noted to run for relatively short durations, which was a significant limitation.  The 366 
longest study was conducted over a two year period, while three studies ran between 11 and 14 367 
months. A further three studies ran for 3 to 3 ½ months, however this was in order to limit 368 
metabolic side effects associated with ART regimens such as lipodystrophy due to the high-fat 369 
content of the RUTF supplement. Still, such a limited follow-up time was considered 370 
insufficient to fully observe the impact of the food intervention. It was also not possible to 371 
monitor the effect of access to and consumption of other food sources, which may have 372 
impacted on the results of weight gain. 373 
 374 
Study Outcomes 375 
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Despite these limitations a key observation made in all studies was that food supplementation 376 
improved weight gain and BMI. Most notably was the 6.3kg weight increase after 12 months 377 
in participants from the study by Cantrell and colleagues (39). Also, in all studies where it was 378 
measured, ART adherence was significantly high among participants receiving food 379 
supplementation. None of the food intervention strategies however had any significant impact 380 
on CD4 cell count in the studies where it was measured. Where measured, mortality rates were 381 
relatively high; and were largely associated with participants that were severely malnourished 382 
and ART naïve (42, 44).   These results are significant and provide justification for future study, 383 
as it highlights the important role food and nutrition security plays in improving overall quality 384 
of life for HIV patients.  385 
  386 
A follow-up to the earlier Ndekha study by the same research group assessed the BMI of 387 
patients subsequent to food supplementation (47). Participants were followed at three and nine 388 
month intervals after the end of the intervention trial. The initial increase in BMI was not 389 
sustained without supplementation, neither was the improvement in ART adherence and 390 
quality of life (47) The study concluded that food supplementation must be maintained 391 
throughout in order to achieve maximum nutritional gains. Clearly, this can only be achieved 392 
with a sustainable nutrition intervention programme.  393 
 394 
Field studies involving nutrition intervention for HIV patients have generally relied on 395 
anthropometric data as primary indicators of supplementation efficacy; however the inclusion 396 
of biochemical parameters such as total antioxidant content (TAC) and lipid peroxidation can 397 
provide substantial information as to the occurrence and extent of nutrition recovery. 398 
Malondialdehyde (MDA) and 4-hydroxynonenal (HNE) are identified as lipid peroxidation end 399 
products, and plasma level measurements have been used to indicate oxidative stress occurring 400 
in the body.   Oxidative stress caused by RS overproduction can be indicative of HIV infection 401 
and/or undernutrition (17) ; which is linked to nutrient malabsorption and wasting in HIV 402 
patients (16).  A 1988 study showed MDA levels to be as much as 30% higher in HIV patients 403 
compared to their HIV negative counterparts (47); whilst a study almost a decade later made 404 
similar observations in children and new-born infants (48). None of the studies indexed in 405 
PUBMED and included in this review made an assessment of biochemical parameters.  406 
 407 
The Food Multi-Mix Concept 408 
14 
 
According to the Food Multi-Mix (FMM) concept described by Zotor and colleagues, a food-409 
based approach to addressing nutritional needs for therapeutic use can be employed as a cost-410 
effective and sustainable means to improving nutrition in HIV patients (50). The aim of the 411 
FMM concept is to achieve affordability, sustainability and acceptance of therapeutic food 412 
supplementation. The FMM concept has been previously described in its utilisation of locally 413 
produced and commonly consumed foods within a community setting for clinically-based 414 
interventions (50). It allows for nutritional support in HIV and wasting syndromes, which is 415 
aimed at replenishing energy and nutrient losses and improving weight gain. In selecting food 416 
ingredients, total energy requirements including additional demands to compensate for altered 417 
metabolism and special roles of nutrients including vitamin A, C, folate and minerals such as 418 
zinc, selenium were all taken into consideration in accordance with specific requirements of an 419 
HIV patient.   420 
In various FMMs, beta carotene (vitamin A equivalent) content was on average 30% above 421 
RNI values per 300 g serving. Two servings would thus provide 60% more than RNI values. 422 
Apart from eggs, the carotene sources of FMMs are mostly plant-derived and are thus more 423 
affordable, thus reducing the cost of meal provision.  HIV patients also require additional 424 
protein to ensure adequate immune system function. The consumption of 200 g of any of the 425 
FMMs can provide at least two-thirds of daily protein requirements and help prevent protein 426 
malnutrition, rebuild lean body mass, and assist with enzyme production. The high protein 427 
content of FMMs can provide the equivalent of 143.4% RNI per serving for a 70 kg man and 428 
286.8% of RNI in two servings per day.  In a study conducted by Amuna and colleagues (51), 429 
it was argued that a 70 kg adult HIV-infected male can meet at least 52.4% of his daily 430 
energy requirement by consuming a 300 g serving of FMM. Regarding energy requirements, 431 
two servings per day of FMM can provide between 2293 kcal (9.56MJ) and 2413 kcal 432 
(10.06MJ), which is equivalent to daily requirements. This can further be enriched by adding 433 
vegetable oils (rich in n-3 and n-6) and sugar where required. A typical high energy FMM 434 
with energy density between 3.82-4.02 kcal/g (15.93-16.76 J/g) may thus offset the weight 435 
loss resulting from abnormally excessive cytokine production e.g. TNF- and IL-1 (51). 436 
The use of plant sources of oils including nuts in FMMs provide n-3 and n-6 unsaturated fatty 437 
acids. The inclusion of saturated fat sources is avoided as hypertriglyceridaemia has been 438 
observed in HIV patients, which can be exacerbated by ART (52). Preliminary results obtained 439 
in the use of FMM concept is encouraging for its application amongst HIV infected individuals 440 
and warrants further investigation.  Furthermore, as most areas heavily affected by HIV are 441 
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resource poor, it is anticipated that a food-based approach would acquire sustainability over 442 
time should locally based foods be utilised.   443 
 444 
Conclusion 445 
The nutritional and metabolic challenges of HIV/AIDS and other cachectic conditions are of 446 
increasing scientific interest. Anti-retroviral therapy and other pharmacological approaches to 447 
management continue to improve prognosis and the quality of life. However, as this review has 448 
shown, these have limited success in the absence of adequate nutritional support. Nutritional 449 
status and weight loss has been a major prognostic index of survival particularly in developing 450 
countries (46). In countries where ART is both unavailable and inaccessible due to cost, 451 
emphasis on using foods with functional properties (nutraceuticals) as a management tool is 452 
warranted.  453 
This review demonstrates an overall consensus that food-based intervention can play a 454 
supportive role in overall weight gain and improving ART adherence. Although BMI is seen 455 
as an important indicator of nutritional recovery, measures such as body protein repletion, 456 
increase in muscle strength, clinical improvements in appetite, and a reduced frequency of 457 
opportunistic infections can further strengthen the argument that nutritional intervention is 458 
integral to HIV palliative care. However, the biochemical processes that occur during HIV 459 
infection require a more thorough investigation. In the studies included in this review, 460 
biochemical data such as micronutrient status and lipid peroxidation were not included in either 461 
baseline or outcome measurements.  In addition, as all but one intervention were based on 462 
imported food interventions, supplementation did not reflect the local diet of participants. 463 
Studies involving locally-produced food supplements, a longer follow-up time and biochemical 464 
measurements may provide more substantial information on the efficacy of nutrition 465 
intervention. The inclusion of locally/community grown crops in therapeutic food production 466 
may considerably lower both ingredient and transport costs, as well as introduce a market for 467 
small-scale community farmers. Support from government and NGOs can also assist in 468 
improving patient access to therapeutic foods. In addition, further investigation is needed into 469 
the clinical efficacy of therapeutic food formulas (including the FMM approach) given to HIV 470 
patients.    471 
 472 
 473 
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